[1] Sommer, N., Dietrich, A., Schermuly, R.T., Ghofrani, H.A., et al. (2008) Regulation of Hypoxic Pulmonary Vasoconstriction: Basic Mechanisms. European Respiratory Journal, 32, 1386-1398.
http://dx.doi.org/10.1183/09031936.00013908
[2] Stenmark, K.R., Fagan, K.A. and Frid, M.G. (2006) Hypoxia-Induced Pulmonary Vascular Remodeling: Cellular and Molecular Mechanisms. Circulation Research, 99, 675-691.
http://dx.doi.org/10.1161/01.RES.0000243584.45145.3f
[3] Ward, J.P. and McMurtry, I.F. (2009) Mechanisms of Hypoxic Pulmonary Vasoconstriction and Old Problem. Current Opinion in Pharmacology, 9, 287-296.
http://dx.doi.org/10.1016/j.coph.2009.02.006
[4] Morrell, N.W., Adnot, S., Archer, S.L., et al. (2009) Cellular and Molecular Basis of Pulmonary Arterial Hypertension. Journal of the American College of Cardiology, 54, S20-S31.
http://dx.doi.org/10.1016/j.jacc.2009.04.018
[5] Ding, L.L., Chapman, A., Boyd, R. and Wang, H.D. (2007) ERK Activation Contributes to Regulation of Spontaneous Contractile Tone via Superoxide Anion in Isolated Rat Aorta of Angiotensin II-Induced Hypertension. American Journal of Physiology—Heart and Circulatory Physiology, 292, H2997-H3005.
http://dx.doi.org/10.1152/ajpheart.00388.2006
[6] Meloche, S. and Pouysségur, J. (2007) TheERK1/2 Mitogen-Activated Protein Kinase Pathway as a Master Regulator of the G1- to S-Phase Transition. Oncogene, 26, 3227-3239.
http://dx.doi.org/10.1038/sj.onc.1210414
[7] Li, M., Liu, Y.L., Dutt, P., Fanburg, B.L. and Toksoz, D. (2007) Inhibition of Serotonin-Induced Mitogenesis, Migration, and ERKMAPK Nuclear Translocation in Vascular Smooth Muscle Cells by Atorvastatin. American Journal of Physiology—Lung Cellular and Molecular Physiology, 293, L463-L471.
http://dx.doi.org/10.1152/ajplung.00133.2007
[8] Yao, Y., Wu, W.Y., Liu, A.H., Deng, S.S., Bi, K.S., Liu, X. and Guo, D.A. (2008) Interaction of Salvianolic Acid and Notoginsengnosides in Inhibition of ADP-Induced Platelet Aggregation. American Journal of Chinese Medicine, 36, 313-328.
http://dx.doi.org/10.1142/S0192415X08005795
[9] Sun, H.X., Pan, H.J. and Pan, Y.J. (2003) Haemolytic Activity and Immunological Adjuvant Effect of Panaxnotoginsengsaponins. Acta Pharmaceutica Sinica, 24, 1150-1154.
[10] Chen, S.W., Li, X.H., Ye, K.H., Jiang, Z.F. and Ren, X.D. (2004) Total Saponins of Panaxnotoginseng Protect Rabbit Iliac Artery against Balloon Endothelial Denudation Injury. Acta Pharmaceutica Sinica, 25, 1151-1156.
[11] Wang, C.Z., McEntee, E., Wicks, S., Wu, J.A. and Yuan, C.S. (2006) Phytochemical and Analytical Studies of Panax notoginseng (Burk.). Journal of Natural Medicines, 60, 97-106.
http://dx.doi.org/10.1007/s11418-005-0027-x
[12] Liu, Y., Hua, Q., Lei, H. and Li, P. (2011) Effect of Tong Luo Jiu Nao on Aβ-Degrading Enzymes in AD Rat Brains. Journal of Ethnopharmacology, 137, 1035-1046.
http://dx.doi.org/10.1016/j.jep.2011.07.031
[13] Ma, W.P., Yang, Y.N., Zhou, D.B. and Zhou, W.Q. (2004) The Preventive Effect of Panax notoginseng saponins (PNS) on Chronic Hypoxic Pulmonary Hypertension in Rats. Chinese Journal of Pathophysiology, 20, 1074-1077.
[14] Li, C.-Y., Deng, W., Liao, X.-Q., Deng, J., Zhang, Y.-K. and Wang, D.-X. (2013) The Effects and Mechanism of Ginsenoside Rg1 on Myocardial Remodeling in an Animal Model of Chronic Thromboembolic Pulmonary Hypertension. European Journal of Medical Research, 18, 16.
http://dx.doi.org/10.1186/2047-783X-18-16
[15] Zhu, A.A., Wang, W.T. and Lin, L.N. (2008) Effect of Panax notoginseng saponins on the Hypoxia and Hypercapnia Induced Pulmonary Vasoconstriction. Journal of Wenzhou Medical College, 38.
[16] Yang, X., Sheares, K.K., Davie, N., et al. (2002) Hypoxic Induction of Cox-2 Regulates Proliferation of Human Pulmonary Artery Smooth Muscle Cells. American Journal of Respiratory Cell and Molecular Biology, 27, 688-696.
http://dx.doi.org/10.1165/rcmb.2002-0067OC
[17] Xu, Y.X., Lin, L.N., Tang, L.L., Zheng, M.X., Ma, Y.C., Huang, L.J., Meng, W. and Wang, W.T. (2014) Notoginsenoside R1 Attenuates Hypoxia and Hypercapnia-Induced Vasocontriction in Isolated Rat Pulmonary Arterial Rings by Reducing the Expression of ERK. The American Journal of Chinese Medicine, 42, 799-816.
http://dx.doi.org/10.1142/S0192415X14500517
[18] Han, W., Tang, X., Wu, H., Liu, Y. and Zhu, D. (2007) Role of ERK1/2 Signaling Pathways in 4-Amino-Pyridine-Induced Rat Pulmonary Vasoconstriction. European Journal of Pharmacology, 569, 138-144.
http://dx.doi.org/10.1016/j.ejphar.2007.04.042
[19] Sommer, N., Die-trich, A., Schermuly, R.T., et al. (2008) Regulation of Hypoxic Pulmonary Vasoconstriction: Basic Mechanism. European Respiratory Journal, 32, 1639-1651.
[20] Li, M., Liu, Y., Dutt, P., et al. (2007) Inhibition of Serotonin-Induced Mitogenesis, Migraiton, and ERKMAPK Nuclear Translocation in Vascular Smooth Muscle Cells by Atorvastatin. American Journal of Physiology—Lung Cellular and Molecular Physiology, 293, L463-L471.
http://dx.doi.org/10.1152/ajplung.00133.2007
[21] Xia, S., Tai, X., Wang, Y., et al. (2011) Involvement of Gax Gene in Hypoxia-Induced Pulmonary Hypertension, Proliferation, and Apoptosis of Arterial Smooth Muscle Cells. American Journal of Respiratory Cell and Molecular Biology, 44, 66-73.
http://dx.doi.org/10.1165/rcmb.2008-0442OC
[22] Sztrymf, B., Souza, R., Bertoletti, L., et al. (2010) Prognostic Factors of Acute Heart Failure in Patients with Pulmonary Arterial Hypertension. European Respiratory Journal, 35, 1286-1293.
http://dx.doi.org/10.1183/09031936.00070209
[23] Welch, L.C., Lecuona, E., Briva, A., Trejo, H.E., Dada, L.A. and Sznajdera, J.I. (2010) Extracellular Signal-Regulated Kinase (ERK) Participates in the Hypercapnia-Induced Na,K-ATPase Down-Regulation. FEBS Letters, 584, 3985-3989.
http://dx.doi.org/10.1016/j.febslet.2010.08.002
[24] Zhu, A., Lin, N., Wang, W.T., Wang, S.H.J., Jin, K.K., Jin, L.D., Wang, Y. and Wang, Q. (2008) Effect of Panax notoginoside on the Hypoxic Hypercapnia Pulmonary Vasoconstriction. Journal of Wenzhou Medical College, 38, 29-32.